TY  - GEN
AU  - Hsieh,Yi-Hsuan
AU  - Su,Ih-Jen
AU  - Yen,Chia-Jui
AU  - Tsai,Ting-Fen
AU  - Tsai,Hung-Wen
AU  - Tsai,Han-Ni
AU  - Huang,Yu-Jun
AU  - Chen,Yen-Yu
AU  - Ai,Yu-Lin
AU  - Kao,Lin-Yuan
AU  - Hsieh,Wen-Chuan
AU  - Wu,Han-Chieh
AU  - Huang,Wenya
TI  - Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients
SN  - 1460-2180
PY  - 2013///0403
KW  - Animals
KW  - Apoptosis
KW  - drug effects
KW  - Blotting, Western
KW  - COP9 Signalosome Complex
KW  - Carcinoma, Hepatocellular
KW  - etiology
KW  - Cell Cycle
KW  - Cell Nucleus
KW  - Cell Proliferation
KW  - Cyclin-Dependent Kinase Inhibitor p27
KW  - genetics
KW  - Cytoplasm
KW  - Female
KW  - Fluorescent Antibody Technique
KW  - Hepatitis B Surface Antigens
KW  - Hepatitis B virus
KW  - Hepatitis B, Chronic
KW  - complications
KW  - Hepatocytes
KW  - cytology
KW  - Histone Deacetylase Inhibitors
KW  - pharmacology
KW  - Humans
KW  - Hydroxamic Acids
KW  - Immunoenzyme Techniques
KW  - Immunoprecipitation
KW  - Intracellular Signaling Peptides and Proteins
KW  - Liver Neoplasms
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Transgenic
KW  - Mutant Proteins
KW  - Mutation
KW  - Nuclear Proteins
KW  - Peptide Hydrolases
KW  - Protein Precursors
KW  - RNA, Messenger
KW  - Real-Time Polymerase Chain Reaction
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - TATA Box Binding Protein-Like Proteins
KW  - Two-Hybrid System Techniques
KW  - Vorinostat
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/carcin/bgs365
ER  -